United Services Automobile Association Purchases Shares of 4,941 The Cooper Companies, Inc. $COO

Key Points

• United Services Automobile Association has taken a new position in The Cooper Companies, Inc. (NASDAQ: COO) by acquiring 4,941 shares valued at approximately $414,000.
• Several institutional investors, including Goldman Sachs, have increased their holdings in Cooper Companies, contributing to 24.39% of the stock being owned by institutional investors.
• Cooper Companies reported a $1.10 EPS for the last quarter, surpassing analysts' expectations of $1.07, with a revenue of $1.06 billion.

United Services Automobile Association purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,941 shares of the medical device company's stock, valued at approximately $414,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its position in shares of Cooper Companies by 3.4% during the first quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company's stock valued at $436,681,000 after acquiring an additional 172,485 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Cooper Companies by 17.0% during the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock valued at $399,340,000 after acquiring an additional 686,751 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Cooper Companies by 12.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company's stock valued at $333,595,000 after acquiring an additional 425,400 shares in the last quarter. Millennium Management LLC boosted its holdings in Cooper Companies by 36.0% in the first quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company's stock worth $217,405,000 after purchasing an additional 682,166 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Cooper Companies by 1.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,836,892 shares of the medical device company's stock worth $168,865,000 after purchasing an additional 18,282 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Performance

Shares of Cooper Companies stock traded down $1.78 on Friday, hitting $66.68. 3,147,814 shares of the company's stock were exchanged, compared to its average volume of 3,323,522. The company has a 50-day simple moving average of $71.53 and a 200-day simple moving average of $75.90. The stock has a market capitalization of $13.26 billion, a PE ratio of 32.85, a PEG ratio of 1.75 and a beta of 0.97. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. The business had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company's revenue was up 5.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, EVP Brian G. Andrews purchased 1,525 shares of the company's stock in a transaction dated Tuesday, September 2nd. The shares were acquired at an average price of $65.68 per share, for a total transaction of $100,162.00. Following the purchase, the executive vice president directly owned 22,191 shares of the company's stock, valued at $1,457,504.88. The trade was a 7.38% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Gerard H. Warner III bought 1,450 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were purchased at an average price of $69.23 per share, for a total transaction of $100,383.50. Following the purchase, the chief operating officer owned 18,319 shares in the company, valued at $1,268,224.37. This represents a 8.60% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 15,975 shares of company stock worth $1,079,566. 1.98% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on COO shares. Wells Fargo & Company dropped their target price on shares of Cooper Companies from $93.00 to $72.00 and set an "overweight" rating on the stock in a report on Thursday, August 28th. BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. UBS Group upgraded shares of Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Piper Sandler dropped their target price on shares of Cooper Companies from $105.00 to $83.00 and set an "overweight" rating on the stock in a report on Thursday, August 28th. Finally, Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and an average price target of $86.64.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.